Impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the PACU: a before and after retrospective study

Backgrounds: Procedures for Postoperative Nausea and Vomiting (PONV) prevention are mostly based on identification of the risk factors before administering antiemetic drugs. The purpose of this study was to evaluate the impact of the extended use of antiemetic on the PONV in the Postanesthetic Care...

Full description

Bibliographic Details
Main Authors: Cyrus Motamed, Gr..goire Weil, Jean Louis Bourgain
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Brazilian Journal of Anesthesiology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0104001421002554
_version_ 1817976209445748736
author Cyrus Motamed
Gr..goire Weil
Jean Louis Bourgain
author_facet Cyrus Motamed
Gr..goire Weil
Jean Louis Bourgain
author_sort Cyrus Motamed
collection DOAJ
description Backgrounds: Procedures for Postoperative Nausea and Vomiting (PONV) prevention are mostly based on identification of the risk factors before administering antiemetic drugs. The purpose of this study was to evaluate the impact of the extended use of antiemetic on the PONV in the Postanesthetic Care Unit (PACU). Methods: Two separate 4-year periods (2007...2010, P1, and (2015...2018, P2) were evaluated. During P1, the protocol consisted of dexamethasone and droperidol for patients with a locally adapted high PONV score, followed by ondansetron for rescue in the PACU. For Period 2, dexamethasone (8 mg) and ondansetron (4 mg) were administered in patients under general or regional anesthesia, or sedation longer than 30 minutes, while droperidol (1.25 mg) in rescue was injected in cases of PONV in the PACU. An Anesthesia Information Management System was used to evaluate the intensity score of PONV (1 to 5), putative compliance, sedation, and perioperative opioid consumption upon arrival in the PACU. Results: A total of 27,602 patients were assessed in P1 and 36,100 in P2. The administration of dexamethasone and ondansetron increased several fold (p < 0.0001). The high PONV scores were more improved in P2 than in P1, with scores (3+4+5) for P1 vs. P2, p < 0.0001. Overall, 99.7% of the patients in P2 were asymptomatic at discharge. Morphine consumption decreased from 6.9..1.5 mg in P1 to 3.5 .. 1.5 mg in P2 (p < 0.0001). Discussion: The extension of pharmacological prevention of PONV was associated with a decrease in the intensity of severe PONV. However, uncertainty regarding confounding factors should not be ignored. IRB: n.. 92012/33465
first_indexed 2024-04-13T22:00:28Z
format Article
id doaj.art-c35493b0694e4dc48bfc9b25df24f947
institution Directory Open Access Journal
issn 0104-0014
language English
last_indexed 2024-04-13T22:00:28Z
publishDate 2022-11-01
publisher Elsevier
record_format Article
series Brazilian Journal of Anesthesiology
spelling doaj.art-c35493b0694e4dc48bfc9b25df24f9472022-12-22T02:28:07ZengElsevierBrazilian Journal of Anesthesiology0104-00142022-11-01726762767Impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the PACU: a before and after retrospective studyCyrus Motamed0Gr..goire Weil1Jean Louis Bourgain2Corresponding author.; Gustave Roussy Institute, Department of Anesthesia, Villejuif, FranceGustave Roussy Institute, Department of Anesthesia, Villejuif, FranceGustave Roussy Institute, Department of Anesthesia, Villejuif, FranceBackgrounds: Procedures for Postoperative Nausea and Vomiting (PONV) prevention are mostly based on identification of the risk factors before administering antiemetic drugs. The purpose of this study was to evaluate the impact of the extended use of antiemetic on the PONV in the Postanesthetic Care Unit (PACU). Methods: Two separate 4-year periods (2007...2010, P1, and (2015...2018, P2) were evaluated. During P1, the protocol consisted of dexamethasone and droperidol for patients with a locally adapted high PONV score, followed by ondansetron for rescue in the PACU. For Period 2, dexamethasone (8 mg) and ondansetron (4 mg) were administered in patients under general or regional anesthesia, or sedation longer than 30 minutes, while droperidol (1.25 mg) in rescue was injected in cases of PONV in the PACU. An Anesthesia Information Management System was used to evaluate the intensity score of PONV (1 to 5), putative compliance, sedation, and perioperative opioid consumption upon arrival in the PACU. Results: A total of 27,602 patients were assessed in P1 and 36,100 in P2. The administration of dexamethasone and ondansetron increased several fold (p < 0.0001). The high PONV scores were more improved in P2 than in P1, with scores (3+4+5) for P1 vs. P2, p < 0.0001. Overall, 99.7% of the patients in P2 were asymptomatic at discharge. Morphine consumption decreased from 6.9..1.5 mg in P1 to 3.5 .. 1.5 mg in P2 (p < 0.0001). Discussion: The extension of pharmacological prevention of PONV was associated with a decrease in the intensity of severe PONV. However, uncertainty regarding confounding factors should not be ignored. IRB: n.. 92012/33465http://www.sciencedirect.com/science/article/pii/S0104001421002554Postoperative nausea and vomiting
spellingShingle Cyrus Motamed
Gr..goire Weil
Jean Louis Bourgain
Impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the PACU: a before and after retrospective study
Brazilian Journal of Anesthesiology
Postoperative nausea and vomiting
title Impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the PACU: a before and after retrospective study
title_full Impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the PACU: a before and after retrospective study
title_fullStr Impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the PACU: a before and after retrospective study
title_full_unstemmed Impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the PACU: a before and after retrospective study
title_short Impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the PACU: a before and after retrospective study
title_sort impact of extending prevention of postoperative nausea and vomiting for cancer surgical patients in the pacu a before and after retrospective study
topic Postoperative nausea and vomiting
url http://www.sciencedirect.com/science/article/pii/S0104001421002554
work_keys_str_mv AT cyrusmotamed impactofextendingpreventionofpostoperativenauseaandvomitingforcancersurgicalpatientsinthepacuabeforeandafterretrospectivestudy
AT grgoireweil impactofextendingpreventionofpostoperativenauseaandvomitingforcancersurgicalpatientsinthepacuabeforeandafterretrospectivestudy
AT jeanlouisbourgain impactofextendingpreventionofpostoperativenauseaandvomitingforcancersurgicalpatientsinthepacuabeforeandafterretrospectivestudy